Close
0
You have no items in your order cart.
Search
Filters

Vaccines

View as Grid List
Sort by
Display per page

Diluvac Forte Prrs - 100ml

124331
Porcilis PRRS is a live freeze-dried vaccine containing at least 104.0 TCID50 of PRRS virus strain DV per dose to be reconstituted with Diluvac Forte containing 75 mg/ml dl-a-tocopherol acetate to a suspension for injection. Used to vaccinate breeding and finishing pigs against reproductive and respiratory problems due to PRRS virus. Growing pigs can be vaccinated from 2 weeks of age; a single 2ml intramuscular vaccination will provide protection against the effects of PRRS virus infection through to slaughter weight. PRRS virus can compromise the health, growth and profitability of growing and finishing pigs by causing respiratory problems. Breeding pigs can also be vaccinated with Porcilis PRRS giving a significant improvement in reproductive performance in PRRS positive farms.

Diluvac Forte Prrs - 200ml

145774
Porcilis PRRS is a live freeze-dried vaccine containing at least 104.0 TCID50 of PRRS virus strain DV per dose to be reconstituted with Diluvac Forte containing 75 mg/ml dl-a-tocopherol acetate to a suspension for injection. Used to vaccinate breeding and finishing pigs against reproductive and respiratory problems due to PRRS virus. Growing pigs can be vaccinated from 2 weeks of age; a single 2ml intramuscular vaccination will provide protection against the effects of PRRS virus infection through to slaughter weight. PRRS virus can compromise the health, growth and profitability of growing and finishing pigs by causing respiratory problems. Breeding pigs can also be vaccinated with Porcilis PRRS giving a significant improvement in reproductive performance in PRRS positive farms.

Diluvac Forte Prrs - 20ml

124341
Porcilis PRRS is a live freeze-dried vaccine containing at least 104.0 TCID50 of PRRS virus strain DV per dose to be reconstituted with Diluvac Forte containing 75 mg/ml dl-a-tocopherol acetate to a suspension for injection. Used to vaccinate breeding and finishing pigs against reproductive and respiratory problems due to PRRS virus. Growing pigs can be vaccinated from 2 weeks of age; a single 2ml intramuscular vaccination will provide protection against the effects of PRRS virus infection through to slaughter weight. PRRS virus can compromise the health, growth and profitability of growing and finishing pigs by causing respiratory problems. Breeding pigs can also be vaccinated with Porcilis PRRS giving a significant improvement in reproductive performance in PRRS positive farms.

Diluvac Forte Prrs - 50ml

124351
Porcilis PRRS is a live freeze-dried vaccine containing at least 104.0 TCID50 of PRRS virus strain DV per dose to be reconstituted with Diluvac Forte containing 75 mg/ml dl-a-tocopherol acetate to a suspension for injection. Used to vaccinate breeding and finishing pigs against reproductive and respiratory problems due to PRRS virus. Growing pigs can be vaccinated from 2 weeks of age; a single 2ml intramuscular vaccination will provide protection against the effects of PRRS virus infection through to slaughter weight. PRRS virus can compromise the health, growth and profitability of growing and finishing pigs by causing respiratory problems. Breeding pigs can also be vaccinated with Porcilis PRRS giving a significant improvement in reproductive performance in PRRS positive farms.

Enteriocolix - 50ml

139424
Entericolix® is an innovative sow vaccine for preventing diarrhoea in piglets caused by E. coli. and C. perfringens Type C. The vaccine reduces mortality and clinical signs caused by E. coli neonatal diarrhoea and Necrotic Enteritis. Entericolix® has the unique claim of extending this protection to piglets until 21 days of age, even after the pigs were weaned.

Enzovax - 20ml

125270
For the active immunisation of susceptible female breeding sheep to reduce abortion caused by Chlamydophila abortus infection. Dosage & Administration • Dose: 2 ml of reconstituted vaccine by intramuscular or subcutaneous injection. • Ewe lambs, where it is intended to breed from them, may be vaccinated from 5 months of age. • Shearlings and older ewes should be vaccinated during the 4 month period prior to mating. • Vaccination must take place at least 4 weeks before mating. Withdrawals: Meat: 7 days.

Enzovax - 40ml

118691
For the active immunisation of susceptible female breeding sheep to reduce abortion caused by Chlamydophila abortus infection. Dosage & Administration • Dose: 2 ml of reconstituted vaccine by intramuscular or subcutaneous injection. • Ewe lambs, where it is intended to breed from them, may be vaccinated from 5 months of age. • Shearlings and older ewes should be vaccinated during the 4 month period prior to mating. • Vaccination must take place at least 4 weeks before mating. Withdrawals: Meat: 7 days.

Equilis Prequenza Te - 1ml x10

107681
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality. Influenza: Onset of immunity - 2 weeks after primary vaccination course Duration of immunity - 5 months after them primary vaccination course. 12 months after the first revaccination Tetanus: Onset of immunity - 2 weeks after the primary vaccination course Duration of immunity - 17 months after the primary vaccination course. 24 months after the first revaccination Revaccination Influenza The first revaccination (third dose) against equine influenza is given 5 months after the primary vaccination course. This revaccination results in immunity to equine influenza lasting at least 12 months. The second revaccination is given 12 months after the first revaccination. The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component. Tetanus The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended

Equilis Prequenza Te - 1ml x5

107671
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality. Influenza: Onset of immunity - 2 weeks after primary vaccination course Duration of immunity - 5 months after them primary vaccination course. 12 months after the first revaccination Tetanus: Onset of immunity - 2 weeks after the primary vaccination course Duration of immunity - 17 months after the primary vaccination course. 24 months after the first revaccination Revaccination Influenza The first revaccination (third dose) against equine influenza is given 5 months after the primary vaccination course. This revaccination results in immunity to equine influenza lasting at least 12 months. The second revaccination is given 12 months after the first revaccination. The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component. Tetanus The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended

Equilis Te - 1ml x10

120291
Active immunisation of horses from 6 months of age against tetanus to prevent mortality. Onset of immunity: 2 weeks after the primary vaccination course. Duration of immunity: 17 months after the primary vaccination course, 24 months after the first revaccination.

Equip EHV 1.4 - 1.5ml

197870
For active immunisation of horses to reduce clinical signs due to infection with Equine Herpesvirus 1 and 4 and to reduce abortion caused by EHV-1 infection. Dosage and administration One dose per horse to be administered by deep intramuscular injection. Primary course A single dose should be administered from 5 months of age followed by a second injection after an interval of 4-6 weeks. In the event of increased infection risk, for example when a foal has consumed insufficient colostrum or there is a risk of early exposure to field infections with EHV-1 or EHV-4, earlier vaccination may be given. In these circumstances the foal should receive a single dose from 3 months of age followed by the above mentioned full primary vaccination course. Booster Following completion of the primary course, a single dose should be administered every 6 months. Use in pregnant mares: To reduce abortion due to EHV-1 infection, pregnant mares should be vaccinated during the 5th, 7th and 9th month of pregnancy with a single 1.5 ml dose on each occasion.

Equip Rotavirus - 1ml x10

146434
For the vaccination of pregnant mares to provide passive transfer of antibodies to foals to reduce the risk of diarrhoea caused by equine rotavirus G3 P12 serotypes. Mares are able to transfer the passive immunity to the foals 4 weeks after the third vaccination. Foals of the vaccinated mares show an increase in antibodies against equine rotavirus for approximately sixty days. Dosage and administration 1.0 ml dose per mare to be administered by deep intramuscular injection. Vaccination Schedule Pregnant mares should be given three doses of vaccine consisting of a single 1ml dose administered at the 8th, 9th and 10th month of each pregnancy.